---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-082005"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:37:32.073040+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics resolves Nasdaq compliance, closes $5M offering, earns $7M license fee from WY Biotech

## Summary
- Nasdaq confirms compliance with bid price and MVPHS rules; company believes full compliance for Capital Market listing.
- Closed $5M follow-on offering (671,140 units at $7.45/unit) and reduced existing warrant exercise price to $7.45.
- WY Biotech license fully binding; HCW Biologics earns $7M upfront fee recognized in Q2 2025.
- Converted $6.6M secured notes into common stock, warrants, and Wugen shares; reduced debt and improved equity.

## SEC filing metadata
- accession: 0000950170-25-082005
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000095017025082005/0000950170-25-082005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000095017025082005/hcwb-20250605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-082005
- JSON: https://secwatch.observer/filing/0000950170-25-082005.json
- Plain text: https://secwatch.observer/filing/0000950170-25-082005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.